Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 2, 2004, Pages 178-185

  Mazumder, Upal Kanti ^a   Gupta, Malaya ^a   Karki, Subhas Somalingappa ^a   Bhattacharya, Shiladitya ^a   Rathinasamy, Suresh ^a   Thangavel, Sivakumar ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Anticancer activity; Hematological profile; Ruthenium complex

Indexed keywords

1,10 PHENANTHROLINE; 2,2' BIPYRIDINE; ACETAZOLAMIDE; CISPLATIN; HEMOGLOBIN; METISAZONE; RUTHENIUM COMPLEX; SEMICARBAZONE DERIVATIVE; THIOSEMICARBAZONE DERIVATIVE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ORGANOMETALLIC COMPOUND; RUTHENIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES CELL; CANCER INHIBITION; CELL SURVIVAL; CHEMICAL ANALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG MECHANISM; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; ERYTHROCYTE COUNT; FINITE ELEMENT ANALYSIS; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CELL SURVIVAL; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 4444317771     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.52.178     Document Type: Article

References (50)

1. Clarke M. J., Zhu F., Frasca D. R., Chem. Rev., 99, 2511-2534 (1999).
2. Kureshy R. I., Khan N. H., Polyhedron, 12, 195-201 (1993) and references theirin.
3. Chakravarty J., Bhattacharya S., Polyhedron, 15, 1047-1055 (1996).
4. Baitalik S., Adhikary B., Polyhedron, 16, 4073-4080 (1997).
5. Keppler B. K., Henn M., Juhl U. M., Berger M. R., Niebi R., Wagner F. E., Prog. Clin. Biochem. Med., 10, 41-69 (1989).
6. Novakova O., Kasparkova J., Vrana O., Van Vliet P. M., Reedijk J., Brabee V., Biochemistry, 34, 12369-12378 (1995).
7. Vilaplana R. A., Gonzalez-Vichez F., Gutierrez-Puebla E., Ruiz-Valero C., Inorg. Chim. Acta, 224, 15-18 (1994).
8. Sava G., Bergamo A., Zorzet S., Gava B., Casarsa C., Cocchietto M., Furlani A., Scarcia V., Serli B., Iengo E., Alessio E., Mestroni G., Eur. J. Cancer, 38, 427-435 (2002).
9. Keppler B. K., Wehe D., Endres H., Rupp W., Inorg. Chem., 26, 844-896 (1987).
10. Keppler B. K., Rupp W., Juhl U. M., Endres H., Nieu R., Balzer W. S., Inorg. Chem., 26, 4366-4370 (1987).
11. Sava G., Ganglirdi R., Bergamo A., Alessio E., Mestroni G., Anticancer Res., 19, 969-972 (1999).
12. Cetinkaya B., Ozdemir I., Binbasioglu B., Durmaz R., Gunal S., Arzneim.-Forsch./Drug. Res., 49, 538-540 (1999).
13. Tysoe S. A., Morgan R. J., Baker D., Strekas T. C., J. Phys. Chem., 97, 1707-1711 (1993).
14. Smith C. A., Sunderland Smith A. J., Keppler B. K., Katz F., Baker E. N., J. Biol. Inorg. Chem., 1, 424-431 (1996).
15. Messori L., Kratz F., Alessio E., Met.-Based Drugs, 3, 1-9 (1996).
16. Frasca D., Ciampa J., Emerson J., Umans R. S., Clarke M. J., Met.- Based Drugs, 3, 197-209 (1996).
17. Clairs S. A., Paul J. D., Platinum Metals Rev., 45, 62-69 (2001).
18. Mazumder U. K., Gupta M., Bera A., Bhattacharya S., Karki S., Manikandan L., Patra S., Indian J. Chem., 42A, 313-317 (2003).
19. Lieber E., Pillai C. N., Hites R. D., Can. J. Chem., 35, 832-842 (1957).
20. Sen A. B., Sengupta S. K., J. Ind. Chem. Soc., 39, 628-634 (1962).
21. Nardelli M., Gasparri G. F., Battislini G. G., Musatti A., Chem. Commun., 1965, 187-188 (1965).
22. Gasparri G. F., Mangia A., Musatti A., Nardelli M., Acta Crystallogr. B, 24, 367-374 (1968).
23. Campbell M. J. M., Coord. Chem. Rev., 15, 179 (1975).
24. Chattopadhyay S. K., Ghosh S. A., Inorg. Chim. Acta, 131, 15-20 (1987).
25. Lieber E., Rao C. N., Pillai C. N., Ramachandran J., Hites R. D., Can. J. Chem., 36, 801-809 (1958).
26. Qi-Xiong Z., Qian-Lin Z., Jin-Ganf L., Bao-Hui Y., Liang-Nian J., Lei W., J. Inorg. Biochem., 78, 293-298 (2000).
27. Anna C. G. H., Marjolein E. T., Brockhui S., Aldrick H. V., Karlijn Van der S., Jaap G. H., Reedijk J., Eur. J. Inorg. Chem., 2002, 369-376 (2002).
28. Pyle A. M., Rehmann J. P., Meshoyrer R., Kumar C. V., Turro J. N., Barton J. K., J. Am. Chem. Soc., 111, 3051-3058 (1989).
29. Morgan R. J., Chatterjee S., Baker D. A., Strekas T. C., Inorg. Chem., 30, 2687-2692 (1991).
30. Prasad S. B., Giri A., Ind. J. Expt. Biol., 32, 155-162 (1994).
31. Doll D. C., Weiss R. B., Cancer Treat. Rev., 10, 185-200 (1983).
32. Beguin Y., Acta Clin. Belg., 51, 36-52 (1996).
33. Pispirigos K., Catsoulakos P., Karakiulakis G., Biochem. Mol. Biol. Int., 31, 565-573 (1993).
34. Ormond P. M., Basinger M. A., Jones M. M., Hande K. R., J. Pharmacol. Exp. Ther., 262, 246-251 (1992).
35. Valentovic M. A., Scott L. A., Madan E., Yokel R. A., Toxicology, 70, 151-162 (1991).
36. Scott L. A., Madan E., Valentovic M. A., Fundam. Appl. Toxicol., 12, 530-539 (1989).
37. Tappel A. L., Fed. Proc., 32, 1870-1874 (1973).
38. Sadzuka Y., Shoji T., Takino Y., Toxicol. Lett., 62, 293-300 (1992).
39. Jeong J. C., Hwang W. M., Yoon C. H., Kim Y. K., Nephron., 88, 241-296 (2001).
40. Hara M., Yoshida M., Nishijima H., Yokosuka M., Ligo M., Ohtani-Kaneko R., Shimada A., Hasegawa T., Akama Y., Hirata K., J. Pineal. Res., 30, 129-138 (2001).
41. Saad S. Y., Najjar T. A., Noredinn A. M., Al-Rikabi A. C., Pharmacol. Res., 43, 193-198 (2001).
42. Antunes L. M., Darin J. D., Bianchi N de L., Pharmacol. Res., 43, 145-150 (2001).
43. Sener G., Satiroglu H., Kabasakal L., Arbak S., Oner S., Ercan F., Keyer-Uysa M., Fundam. Clin. Pharmacol., 14, 553-560 (2000).
44. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests, 6th ed.: Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, PA, 1999.
45. Marvel C. S., Heirs G. S., "Organic Synthesis Collections," 2nd ed., Vol. I, ed. by Blatt A. H., John Wiley & Sons Inc., New York, 1941.
46. John H., Ingleby R. F., J. Chem. Soc., 1958, 3639-3640 (1958).
47. Giordano P. J., Bock C. R., Wrighton M. S., J. Am. Chem. Soc., 100, 6960-6966 (1978).
48. Litchfield J. T., Jr., Wilcoxon F., J. Pharmacol. Exp. Ther., 96, 99-113 (1958).
49. Dacie J. V., Lewis S. M., "Practical Hematology," J. A. Churchill Livingston, Medical Division of Longmann Gr., London, 1958, p. 38.
50. Vaidyanathan V. G., Nair B. U., J. Inorg. Biochem., 91, 405-412 (2002).